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Fayoumi chickens are believed to be more disease resistant compared to commercial broiler chickens. 
The objective of this study was to compare mRNA expression of intestinal nutrient transporters, digestive 
enzymes, and host defense peptides (HDP) between Eimeria maxima-challenged Fayoumi and Ross 
broiler chickens. At 21 d of age, Ross broilers and Fayoumi lines M5.1 and M15.2 were challenged with 
1,000 E. maxima oocysts. Control birds were not challenged. Duodenum, jejunum, and ileum were 
sampled (n = 6) at 7 d post challenge. Gene expression was analyzed using relative quantification PCR. 
Data were analyzed by ANOVA and significance level was set at P < 0.05. There was numerical, but not 
statistically significant, differential weight gain depression for Ross (15%) and Fayoumi lines M5.1 (21%) 
and M15.2 (22%) and significant line-specific changes in gene expression. For nutrient transporters, there 
was downregulation of mRNA for the brush border membrane, amino acid transporters b0,+ AT/rBAT, Bo 
AT, and EAAT3 in different segments of the small intestine of Ross and both lines of Fayoumi chickens, 
indicating that E. maxima challenge likely caused a decrease in nutrient uptake. For HDP, there was 
downregulation of avian beta defensin (AvBD) 1, 6, 10, 12, and 13 mRNA in the jejunum of the 2 Fayoumi 
lines, but no change in the Ross broilers. In the duodenum, there was upregulation of AvBD10 mRNA in 
the Ross and both Fayoumi lines and additionally upregulation of AvBD11, 12, and 13 mRNA in only 
Fayoumi line M15.2. Liver expressed antimicrobial peptide 2 (LEAP2) mRNA was downregulated in the 
duodenum and jejunum of Ross and Fayoumi line M5.1 but not in Fayoumi line M15.2. The homeostatic, 
non-challenged levels of AvBD mRNA were greater in Fayoumi line M15.2 than Ross and Fayoumi line 
M5.1 in the duodenum and ileum. This study demonstrates tissue- and genetic line-specific 
transcriptional responses to E. maxima, highlights novel potential candidate genes for response to 
coccidiosis, and confirms a role for several previously reported genes in response to coccidiosis. 
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MOLECULAR AND CELLULAR BIOLOGY
Differential expression of intestinal nutrient transporters and host defense
peptides in Eimeria maxima-infected Fayoumi and Ross chickens
S. Su,∗,1 K.B. Miska,† R.H. Fetterer,‡ M.C. Jenkins,‡ S.J. Lamont,§ and E.A. Wong∗,2
∗Department of Animal and Poultry Sciences, Virginia Tech, Blacksburg, VA 24061, USA; †Animal Biosciences
and Biotechnology Laboratory, USDA/ARS, Beltsville, MD 20705, USA; ‡Animal Parasitic Diseases Laboratory,
USDA/ARS, Beltsville, MD 20705, USA; and §Department of Animal Science, Iowa State University, Ames, IA
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ABSTRACT Fayoumi chickens are believed to be
more disease resistant compared to commercial broiler
chickens. The objective of this study was to com-
pare mRNA expression of intestinal nutrient trans-
porters, digestive enzymes, and host defense peptides
(HDP) between Eimeria maxima-challenged Fayoumi
and Ross broiler chickens. At 21 d of age, Ross broil-
ers and Fayoumi lines M5.1 and M15.2 were challenged
with 1,000 E. maxima oocysts. Control birds were not
challenged. Duodenum, jejunum, and ileum were sam-
pled (n = 6) at 7 d post challenge. Gene expression
was analyzed using relative quantification PCR. Data
were analyzed by ANOVA and significance level was
set at P< 0.05. There was numerical, but not statis-
tically significant, differential weight gain depression
for Ross (15%) and Fayoumi lines M5.1 (21%) and
M15.2 (22%) and significant line-specific changes in
gene expression. For nutrient transporters, there was
downregulation of mRNA for the brush border mem-
brane, amino acid transporters b0,+AT/rBAT, BoAT,
and EAAT3 in different segments of the small intes-
tine of Ross and both lines of Fayoumi chickens, in-
dicating that E. maxima challenge likely caused a de-
crease in nutrient uptake. For HDP, there was down-
regulation of avian beta defensin (AvBD) 1, 6, 10,
12, and 13 mRNA in the jejunum of the 2 Fayoumi
lines, but no change in the Ross broilers. In the duo-
denum, there was upregulation of AvBD10 mRNA in
the Ross and both Fayoumi lines and additionally up-
regulation of AvBD11, 12, and 13 mRNA in only Fay-
oumi line M15.2. Liver expressed antimicrobial peptide
2 (LEAP2) mRNA was downregulated in the duodenum
and jejunum of Ross and Fayoumi line M5.1 but not in
Fayoumi line M15.2. The homeostatic, non-challenged
levels of AvBD mRNA were greater in Fayoumi line
M15.2 than Ross and Fayoumi line M5.1 in the duo-
denum and ileum. This study demonstrates tissue-
and genetic line-specific transcriptional responses to E.
maxima, highlights novel potential candidate genes for
response to coccidiosis, and confirms a role for sev-
eral previously reported genes in response to coccid-
iosis.
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INTRODUCTION
Fayoumi chickens originated in Egypt where they are
used for both meat and table egg production (Hassan
et al., 2002). These chickens were imported into the
USA in 1954, primarily because of their resistance to
avian leukosis (Kim et al., 2008). The Fayoumi breed
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is more resistant to coccidiosis compared to commer-
cial breeds (Pinard-van der Laan et al., 1998). Two
congenic Fayoumi lines (M5.1 and M15.2) have been
developed that are genetically distant from commercial
broiler and Leghorn lines, highly inbred, and differ only
at the major histocompatibility complex (Zhou and
Lamont, 1999). The Fayoumi line M5.1 showed greater
resistance to Eimeria maxima infection compared to
line M15.2, based on difference in body weight (BW)
gain after challenge (Kim et al., 2008).
The weight gain depression observed following Eime-
ria infection is likely due to damage to the intestinal
epithelial layer and the resultant decrease in expression
of digestive enzymes and nutrient transporters. The
mRNA expression profiles of several digestive enzymes
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and amino acid, peptide, monosaccharide, and mineral
transporters in the intestine of layers and broilers chal-
lenged with E. acervulina, E. maxima, E. tenella, or
E. praecox have been reported (Paris and Wong, 2013;
Fetterer et al., 2014; Su et al., 2014, 2015; Yin et al.,
2015; Miska and Fetterer, 2017). These genes showed
tissue- and age-specific expression profiles depending
upon the chicken breed and Eimeria species used. There
was, however, a common set of mRNA that was down-
regulated in all of these studies. There was downregula-
tion of mRNA for the amino acid transporters b0,+AT
and EAAT3, which are located at the brush border
membrane and downregulation of the zinc transporter
ZnT1 located at the basolateral membrane. The amino
acid transporter b0,+AT mediates the exchange of extra-
cellular cationic amino acids and cystine for intracellu-
lar neutral amino acids (Fotiadis et al., 2013), whereas
the amino acid transporter EAAT3 mediates the up-
take of anionic amino acids, such as glutamate (Kanai
et al., 2013). The zinc transporter ZnT1 mediates the
efflux of zinc out of the cell (Huang and Tepaamorn-
dech, 2013). These changes in gene expression may lead
to a decrease in the intracellular pools of key nutrients
and disruption of zinc balance, which may represent a
cellular mechanism to inhibit Eimeria replication in the
intestinal enterocytes.
Innate immunity is the first line of host defense
against pathogens in vertebrate animals (Dziarski,
2013). Host defense peptides (HDP) are important
components of innate immunity, have antimicrobial
and immunomodulatory properties, and show broad-
spectrum activity against a range of bacteria, fungi,
and enveloped viruses (Robinson et al., 2015). In aves,
the HDP consist of 14 avian beta-defensins (AvBD),
4 cathelicidins, and liver expressed antimicrobial
peptide-2 (LEAP2) (Cuperus et al., 2013; Zhang and
Sunkara, 2014). The AvBD consist of 59 to 104 amino
acids, contain 6 conserved cysteines, and show biologi-
cal activity against a broad range of Gram-positive and
Gram-negative bacteria (Zhang and Sunkara, 2014).
Expression of AvBD mRNA in the intestine of Eimeria-
challenged chickens is variable (Su et al., 2017). LEAP2
is a 40-amino-acid cationic peptide that has broad-
acting antimicrobial activity against several bacterial
pathogens (Townes et al., 2009). In broilers and layers,
E. acervulina, E. maxima, E. tenella, or E. praecox
challenge resulted in downregulation of LEAP2 mRNA
in the small intestine (Casterlow et al., 2011; Sumners
et al., 2011; Paris and Wong, 2013; Fetterer et al., 2014;
Su et al., 2014, 2015, 2017). This suggests that upon
invasion of the intestinal epithelia, Eimeria causes
downregulation of LEAP2, which may enhance its
survival.
The objective of this study was to compare the
mRNA expression of digestive enzymes, nutrient trans-
porters, and HDP in E. maxima-infected Ross broilers
and 2 lines of Fayoumi chickens.
MATERIAL AND METHODS
Chickens and Eimeria Infection
Male Ross Heritage broilers were obtained from Lon-
genecker’s Hatchery (Elizabethtown, PA), and Fayoumi
line M5.1 and M15.2 chicks were obtained from the
Iowa State University flock. The Fayoumi chicks were
shipped on day of hatch from Iowa State University to
the USDA-ARS facility (Beltsville, MD), where they
were housed and maintained in coccidia-free housing.
Chickens were provided ad libitum access to water and
a standard starter-type corn-soybean meal that was for-
mulated to meet NRC requirements for poultry (Na-
tional Research Council, 1994). At 21 d of age, chickens
were inoculated with 1,000 E. maxima oocysts (USDA
APU1 isolate) via oral gavage. Oocysts were main-
tained and isolated as previously described by Fetterer
and Barfield (2003). Seven days post infection (dpi),
duodenum, jejunum, and ileum were collected from
control (n = 6) and challenged birds (n = 6). The con-
tents of the intestine were removed, and tissue segments
(2 to 3 cm) were immediately stored individually in
RNAlater (Thermo-Fisher Scientific, Waltham, MA).
Body weight was recorded at 21 and 28 d (7 dpi) for
weight gain calculation. This study was carried out un-
der a protocol approved by the Beltsville Research Cen-
ter Animal Care and Use Committee and conducted at
the Animal Parasitic Disease Laboratory (USDA Agri-
cultural Research Service, Beltsville, MD).
RNA Extraction and Quantitative Real-Time
PCR
A 20 to 30 mg sample of frozen tissue was homoge-
nized in TriReagent (Molecular Research Center Inc.,
Cincinnati, OH), and total RNA was extracted fol-
lowing the manufacturer’s instruction for the Directzol
RNA MiniPrep Kit (Zymo Research, Irvine, CA). RNA
quantity and purity were determined using a Nanodrop
1000 spectrophotometer (Thermo Fisher Scientific),
and RNA quality was assessed by agarose-formaldehyde
gel electrophoresis. The cDNA was synthesized from to-
tal RNA (500 ng) using the high-capacity cDNA reverse
transcription kit (Thermo Fisher Scientific) and then
diluted 1:30 for real-time PCR analysis. The forward
and reverse primers for all genes analyzed in this study
are shown in Table 1. Primers for β-actin and the ribo-
somal proteins (cRPL4, cRPLP0, and cRPLP1) were
tested as reference genes. Following geNorm analysis,
the 2 most stable genes (cRPL4 and cRPLP1) were
identified and the geometric mean of these 2 genes was
used as the reference gene (Vandesompele et al., 2002).
qPCR was performed on an Applied Biosystems 7500
system using Fast SYBR green (Thermo Fisher Scien-
tific) and the following conditions for all genes: 95◦C for
20 s followed by 40 cycles of 95◦C for 3 s and 60◦C for
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Table 1. Forward and reverse primers for quantitative PCR.
Gene Description1 Forward primer (5′→3′) Reverse primer (5′→3′) Amplicon size (bp) Accession no.
APN AATACGCGCTCGAGAAAACC AGCGGGTACGCCGTGTT 70 NM 204861.1
b0,+AT SLC7A9 CAGTAGTGAATTCTCTGAGTG
TGAAGCT
GCAATGATTGCCACAACTACCA 88 NM 001199133.1
rBAT SLC3A1 CCCGCCGTTCAACAAGAG AATTAAATCCATCGACTCCTTTGC 70 XM 004935370.2
BoAT SLC6A19 GGGTTTTGTGTTGGCTTAGGAA TCCATGGCTCTGGCAGAGAT 60 XM 419056.5
EAAT3 SLC1A1 TGCTGCTTTGGATTCCAGTGT AGCAATGACTGTAGTGCAGAAG
TAATATATG
79 XM 424930.5
SI CGCAAAAGCACAGGGACAGT TCGATACGTGGTGTGCTCAGTT 138 XM 015291762.1
GLUT2 SLC2A2 CACACTATGGGCGCATGCT ATTGTGCCTGGAGGTGTTGGT 68 NM 207178
SGLT1 SLC5A1 GCCATGGCCAGGGCTTA CAATAACCTGATCTGTGCACCAGTA 71 NM 001293240.1
ZnT1 SLC22A18 TCCGGGAGTAATGGAAATCTTC AATCAGGAACAAACCTATGGGAAA 67 XM 421021.4
AvBD1 GAGTGGCTTCTGTGCATTTCTG TTGAGCATTTCCCACTGATGAG 62 NM 204993.1
AvBD6 GCCCTACTTTTCCAGCCCTATT GGCCCAGGAATGCAGACA 63 NM 001001193
AvBD10 CAGACCCACTTTTCCCTGACA CCCAGCACGGCAGAAATT 64 NM 001001609.2
AvBD11 GGTACTGCATCCGTTCCAAAG GCATGTTCCAAATGCAGCAA 56 NM 001001779.1
AvBD12 TGTAACCACGACAGGGGATTG GGGAGTTGGTGACAGAGGTTT 114 NM 001001607.2
AvBD13 CAGCTGTGCAGGAACAACCA CAGCTCTCCATGTGGAAGCA 59 NM 001001780.1
LEAP2 CTCAGCCAGGTGTACTGTGCTT CGTCATCCGCTTCAGTCTCA 66 NM 001001606.1
β-actin GTCCACCGCAAATGCTTCTAA TGCGCATTTATGGGTTTTGTT 78 NM 205518.1
cRPL4 TCAAGGCGCCCATTCG TGCGCAGGTTGGTGTGAA 55 NM 001007479.1
cRPLP0 GCGATTGCTCCCTGTGATG TCTCAGGTCCGAGACCAGTGT 59 NM 204987.2
cRPLP1 TCTCCACGACGACGAAGTCA CCGCCGCCTTGATGAG 63 NM 205322.1
1SLC is the Solute carrier name for the transporter.
30 s. Samples were run in duplicate and relative gene
expression data were analyzed using the 2−ΔΔCt method
(Livak and Schmittgen, 2001), as described in Su et al.
(2015). The mean ΔCt of the uninfected samples was
used to calculate the ΔΔCt value, which was performed
separately for each line.
Statistical Analysis
All data were analyzed by ANOVA using JMP R© Sta-
tistical Discovery Software (SAS Institute, Cary, NC).
For Eimeria-induced gene expression of each line, the
model included the main effects of infection, sorted by
tissue and genes. Significance level was set at P< 0.05
when compared with the control. For homeostatic HDP
gene expression, the ΔCt values were analyzed by gene
within a tissue. Means were separated using Tukey’s
test and significance level was set at P< 0.05.
RESULTS
Body Weight Gain During Eimeria Challenge
The BW of the Fayoumi line M5.1 and M15.2 chick-
ens used for the challenged and unchallenged groups
was 17.2% and 20.6% of the BW of the Ross chickens,
on the day of challenge (day 21). Seven days post chal-
lenge with 1,000 E. maxima oocysts per chicken, there
was a 15% weight gain depression in Ross chickens, a
21% weight gain depression in Fayoumi line M5.1, and
a 22% weight gain depression in Fayoumi line M15.2
(Table 2). This difference in weight gain depression
was not significantly different between the Ross and
Fayoumi lines M5.1 and M15.2.
Gene Expression in E. maxima-Challenged
Chickens
The mRNA abundance of digestive enzymes, nutri-
ent transporters, and HDP during E. maxima infection
was assessed by qPCR in the small intestine of Ross
chickens and Fayoumi lines M5.1 and M15.2. Changes
in gene expression were analyzed separately for duode-
num, jejunum, and ileum.
In the duodenum, Ross broilers challenged with E.
maxima showed downregulation of b0,+AT, EAAT3,
SI, and GLUT2 mRNA compared to uninfected con-
trols (Figure 1A). Fayoumi line M5.1 challenged with
E. maxima showed decreased mRNA expression of the
digestive enzymes APN and SI and all transporters
(b0,+AT, rBAT, B0AT, EAAT3, GLUT2, SGLT1, and
ZnT1) compared to control, whereas challenged Fay-
oumi line M15.2 showed downregulation of b0,+AT,
rBAT, B0AT, EAAT3, and ZnT1 mRNA compared
to control. For the HDP in comparison to the con-
trol (Figure 1B), E. maxima challenge caused a down-
regulation of AvBD1, 6, 13, and LEAP2 mRNA in
Fayoumi line M5.1 and downregulation of only LEAP2
mRNA in Ross chickens. There was upregulation of
AvBD10, 11, 12, and 13 mRNA in challenged Fay-
oumi line M15.2. In addition, there was upregulation
of AvBD10 mRNA in both Ross and Fayoumi line
M5.1.
In the jejunum, E. maxima-challenged Ross broil-
ers showed decreased mRNA expression of APN
and nutrient transporters b0,+AT, rBAT, B0AT, and
EAAT3 (Figure 2A). Challenged Fayoumi line M5.1
showed downregulation of APN, SI, and all transporter
(b0,+AT, rBAT, B0AT, EAAT3, GLUT2, SGLT1, and
ZnT1) mRNA, whereas challenged Fayoumi line M15.2
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Table 2. Body weight gain of Eimeria challenged broilers.
Ross Fayoumi M5.1 Fayoumi M15.2
Breed
Measurement1 BW day 21 BW day 28 BWG BW day 21 BW day 28 BWG BW day 21 BW day 28 BWG
Non-infected 817 ± 24 1311 ± 47 494 ± 28 138 ± 7 208 ± 7 70 ± 3 161 ± 6 233 ± 6 72 ± 2
Infected 725 ± 58 1144 ± 79 418 ± 24 127 ± 11 182 ± 14 55 ± 3 157 ± 4 213 ± 3 56 ± 2
Weight gain depression 15% 21% 22%
P value <0.05 <0.01 <0.001
1BW = Body weight and BWG = Body weight gain; all body weight measurements were expressed as mean ± SE; BW and BWG were measured
in gram.
Figure 1. mRNA expression of digestive enzymes, nutrient transporters, and host defense peptides in the duodenum of Ross and Fayoumi
lines M5.1 and M15.2 chickens challenged with 1,000 E. maxima oocysts. (A) Digestive enzymes and nutrient transporters include aminopeptidase
N (APN), the dimeric neutral/cationic amino acid transporter b0,+AT/rBAT, the neutral amino acid transporter B0AT, the anionic amino acid
transporter EAAT3, sucrase isomaltase (SI), the facilitated monosaccharide transporter GLUT2, the sodium glucose transporter SGLT1, and the
zinc transporter ZnT1. (B) Host defense peptides include the avian beta defensins (AvBD) and liver expressed antimicrobial peptide 2 (LEAP2).
Controls (non-challenged) are equal to a fold change of 1.0 for each gene. ∗ indicates statistical significance from control at P< 0.05.
showed decreased b0,+AT, B0AT, and EAAT3 mRNA.
For the HDP, challenged Fayoumi lines M5.1 and M15.2
showed downregulation of all AvBD mRNA, but there
were no changes in Ross chickens (Figure 2B). For
LEAP2 mRNA, there was downregulation in Ross and
Fayoumi line M5.1, but no changes in Fayoumi line
M15.2.
In the ileum, E. maxima-challenged Ross broilers
showed downregulation of APN and the nutrient trans-
porters b0,+AT, rBAT, B0AT, EAAT3, GLUT2, and
ZnT1 mRNA (Figure 3A). Challenged Fayoumi line
M5.1 showed only decreased EAAT3 mRNA, whereas
challenged Fayoumi line M15.2 showed downregulation
of all genes examined (APN, b0,+AT, rBAT, B0AT,
EAAT3, SI, GLUT2, SGLT1, and ZnT1). For the
HDP, challenged Ross broilers showed only decreased
LEAP2 mRNA and no changes for AvBD mRNA
(Figure 3B). Challenged Fayoumi line M5.1 showed de-
creased mRNA expression of all AvBD, whereas chal-
lenged Fayoumi line M15.2 showed downregulation of
AvBD6, 11, 12, and LEAP2 mRNA.
To better visualize differences in gene expression be-
tween Ross chickens and the Fayoumi lines, a graphical
summary is shown in Table 3. A few general patterns
emerge. For the transporters, there was downregula-
tion of mRNA for all digestive enzymes (APN and SI)
and nutrient transporters (amino acids, sugars, zinc) in
the duodenum and jejunum of Fayoumi line M5.1 and
ileum of Fayoumi line M15.2. There was downregula-
tion of APN and the amino acid transporters in the je-
junum and ileum of Ross chickens. For the HDP, there
was downregulation of all AvBD in the jejunum and
ileum of Fayoumi line M5.1 and the jejunum of Fay-
oumi line M15.2, but not in Ross chickens. Only a few
AvBD mRNA were upregulated following E. maxima
challenge. AvBD10 mRNA was upregulated in the duo-
denum of Ross chickens and both Fayoumi lines and
AvBD11, 12, and 13 mRNA were upregulated in the
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Figure 2. mRNA expression of digestive enzymes, nutrient transporters, and host defense peptides in the jejunum of Ross and Fayoumi lines
M5.1 and M15.2 chickens challenged with 1,000 E. maxima oocysts. (A) Digestive enzymes and nutrient transporters include aminopeptidase
N (APN), the dimeric neutral/cationic amino acid transporter b0,+AT/rBAT, the neutral amino acid transporter B0AT, the anionic amino acid
transporter EAAT3, sucrase isomaltase (SI), the facilitated monosaccharide transporter GLUT2, the sodium glucose transporter SGLT1, and the
zinc transporter ZnT1. (B) Host defense peptides include the avian beta defensins (AvBD) and liver expressed antimicrobial peptide 2 (LEAP2).
Controls (non-challenged) are equal to a fold change of 1.0 for each gene. ∗ indicates statistical significance from control at P< 0.05.
Table 3. Summary of changes in gene expression.
Ross Fayoumi M5.1 Fayoumi M15.2
Gene1 Duo Jej Ile Duo Jej Ile Duo Jej Ile
APN ↓ ↓ ↓ ↓ ↓
bo,+AT ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
rBAT ↓ ↓ ↓ ↓ ↓ ↓
BoAT ↓ ↓ ↓ ↓ ↓ ↓ ↓
EAAT3 ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓ ↓
SI ↓ ↓ ↓ ↓
GLUT2 ↓ ↓ ↓ ↓ ↓
SGLT1 ↓ ↓ ↓
ZnT1 ↓ ↓ ↓ ↓ ↓
AvBD1 ↓ ↓ ↓ ↓
AvBD6 ↓ ↓ ↓ ↓ ↓
AvBD10 ↑ ↑ ↓ ↓ ↑ ↓
AvBD11 ↓ ↓ ↑ ↓ ↓
AvBD12 ↓ ↓ ↑ ↓ ↓
AvBD13 ↓ ↓ ↑ ↓
LEAP2 ↓ ↓ ↓ ↓ ↓ ↓
1↓ and ↑ indicate downregulation and upregulation, respectively, of mRNA abundance relative to control in the duodenum
(Duo), jejunum (Jej), and ileum (Ile).
duodenum of Fayoumi line M15.2. LEAP2 mRNA was
downregulated in all 3 intestinal segments in Ross chick-
ens, but was downregulated in only selected intestinal
segments in Fayoumi lines M5.1 and M15.2.
The homeostatic expression levels of HDP mRNA
may also play an important role in regulating an Eime-
ria infection. The relative homeostatic levels (ΔCt)
of AvBD and LEAP2 mRNA for the Ross and Fay-
oumi lines are shown in Figure 4. In the duodenum,
Fayoumi line M15.2 had greater expression of all AvBD
and LEAP 2 mRNA compared to Ross and Fayoumi
line M5.1. For AvBD10 and AvBD13, Fayoumi line
M5.1 had greater homeostatic expression than Ross
chickens. In the jejunum, Fayoumi line M15.2 had lower
AvBD10, 11, and 13 mRNA than Ross chickens, with
Fayoumi line M5.1 intermediate. In contrast, expression
of LEAP2 mRNA was greater in Fayoumi line M15.2
than line M5.1, with Ross chickens intermediate. In
the ileum, there was a similar pattern as seen in the
duodenum. Fayoumi line M15.2 had greater expression
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Figure 3. mRNA expression of digestive enzymes, nutrient transporters, and host defense peptides in the ileum of Ross and Fayoumi lines
M5.1 and M15.2 chickens challenged with 1,000 E. maxima oocysts. (A) Digestive enzymes and nutrient transporters include aminopeptidase
N (APN), the dimeric neutral/cationic amino acid transporter b0,+AT/rBAT, the neutral amino acid transporter B0AT, the anionic amino acid
transporter EAAT3, sucrase isomaltase (SI), the facilitated monosaccharide transporter GLUT2, the sodium glucose transporter SGLT1, and the
zinc transporter ZnT1. B. Host defense peptides include the avian beta defensins (AvBD) and liver expressed antimicrobial peptide 2 (LEAP2).
Controls (non-challenged) are equal to a fold change of 1.0 for each gene. ∗ indicates statistical significance from control at P< 0.05.
of all AvBD mRNA compared to Ross and Fayoumi
line M5.1. For LEAP2 mRNA, Fayoumi line M5.1 was
greater than line M15.2 and Ross chickens.
DISCUSSION
Fayoumi chickens have been reported to be more re-
sistant to Eimeria infection when compared to other
chicken breeds. For example, Pinard-van der Laan et al.
(1998) compared the resistance of 5 lines of chickens (2
Egyptian lines: Mandarah and Fayoumi, Rhode Island
Red and 2 White Leghorn lines: WLB21 and WLDW)
to challenge with 150,000 E. tenella oocysts at 26 d of
age. The Fayoumi line was the most resistant, showing
no mortality, less severe lesions, and only a 30% weight
gain depression 10 d after infection. The WLDW line
was the most susceptible and showed an 85% weight
gain depression. Kim et al. (2008) compared Fayoumi
lines M5.1 and M15.2 following challenge with 10,000
E. maxima oocysts at 4 wk of age. At 9 dpi, Fayoumi
line M5.1 was more resistant to E. maxima infection
compared to line M15.2. Fayoumi line M5.1 showed no
change in BW, whereas line M15.2 showed a 20% weight
gain depression. Lee et al. (2016) compared the suscep-
tibility of Fayoumi lines M5.1 and M15.2 to an initial
challenge with 5 × 104 E. tenella oocysts at 4 wk of
age, followed by a second challenge with 5 × 106 E.
tenella oocysts 10 d after the initial challenge. At 9 d
following the initial challenge, there was no difference in
weight gain between infected and uninfected Fayoumi
line M5.1, but there was a significant weight loss for
infected compared to uninfected Fayoumi line M15.2.
After the secondary challenge, however, both Fayoumi
lines M5.1 and M15.2 showed weight losses relative to
their respective controls, with the weight loss of line
M15.2 (39%) greater than line M5.1 (32.7%).
In our experiment, we did not observe the expected
differences in BW gain between the Fayoumi lines M5.1
and M15.2 and the Ross broilers or between Fayoumi
line M5.1 and line M15.2 in response to an E. maxima
infection. The Ross and Fayoumi chickens all showed
a similar (15 to 22%) weight gain depression following
challenge with 1,000 E. maxima oocysts at 3 wk of
age. Because the Ross chickens were approximately 5
times heavier than the Fayoumi chickens at the time of
challenge, a similar dosage might have been expected
to affect the Fayoumi lines more than the Ross broilers,
but it did not. The alternative approach would have
been to challenge the Ross and Fayoumi chickens at
the same weight, but then they would have been of
different age. We opted for challenge at the same age,
rather than weight. It is not clear why we did not
observe a differential response of the 2 Fayoumi lines to
E. maxima infection as reported by Kim et al. (2008).
The different results could be due to differences in the
E. maxima dosage (1,000 vs. 10,000 oocysts), age at
challenge (3 vs. 4 wk), time of infection (7 vs. 9 d,) or
the potency or pathogenicity of the E. maxima strain
used. The E. maxima APU1 strain that was used in
this study is a very pathogenic strain compared to
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Figure 4. Homeostatic mRNA levels of the host defense peptides in the small intestine of Ross and Fayoumi lines M5.1 and M15.2 chickens.
Host defense peptides include the avian beta defensins (AvBD) and liver expressed antimicrobial peptide 2 (LEAP2). ΔCt = Ct (HDP)-Ct
(reference gene). Bars with a different letter (a–c) are significantly different (P < 0.05) within a gene and intestinal segment, when analyzed with
Tukey’s test.
most field isolates. Jenkins et al. (2017) showed that
E. maxima strain APU1 caused a greater reduction in
BW, higher lesion scores, and increased oocyst output
compared to the less pathogenic E. maxima strain
APU2.
Expression of intestinal amino acid, peptide, sugar,
and mineral transporters has been previously studied in
chickens challenged with various species of Eimeria. In
the current study, we analyzed both males and females
for the 2 Fayoumi lines because the sexes cannot be
visually distinguished at the age they were tested, but
only male Ross broilers. Kaminski and Wong (2018)
reported that there was no difference between male
and female Aviagen chickens in the expression of sev-
eral nutrient transporters, including the amino acid
transporters b0,+AT, ASCT1, and y+LAT2, the peptide
transporter PepT1, and the sugar transporters SGLT1
and GLUT2 at day 7 and 14 post hatch, although there
was a difference at day of hatch.
Downregulation of the mRNA for the amino acid
transporters b0,+AT and EAAT3 and the zinc trans-
porter ZnT1 have been reported following challenge
with different Eimeria species in both layers and broil-
ers (Paris and Wong, 2013; Fetterer et al., 2014; Su
et al., 2014, 2015; Yin et al., 2015; Miska and Fet-
terer, 2017). The results of the current study show a
similar pattern with downregulation of EAAT3 in all
small intestinal segments of Ross broilers and both Fay-
oumi lines and downregulation of b0,+AT mRNA in all
intestinal segments of Ross broilers and Fayoumi line
M15.2 but only the duodenum and jejunum of Fay-
oumi line M5.1. Furthermore, there was tissue-specific
expression of transporter mRNA between challenged
Fayoumi lines M5.1 and M15.2, which demonstrated
that these 2 lines responded differently to an Eime-
ria challenge. A model has been previously proposed to
describe these changes in transporter expression dur-
ing an Eimeria infection (Paris and Wong, 2013; Su
et al., 2014, 2015). Downregulation of b0,+AT and
EAAT3 mRNA could lead to decreased uptake of
cationic amino acids such as lysine and anionic amino
acids, such as glutamate, of which the latter is impor-
tant because it serves as the major energy source for
intestinal epithelial cells (Brosnan and Brosnan, 2013).
The changes in transporter gene expression that occur
following an Eimeria challenge in the Fayoumi lines are
similar to those documented in broilers and layers, sug-
gesting that there is a common cellular response to an
Eimeria infection in chickens.
In addition to glutamate, b0,+AT also transports
cystine, the oxidized form of cysteine (Fotiadis
et al., 2013). Downregulation of b0,+AT and the anionic
(EAAT3) and neutral (B0AT) amino acid transporters
would lead to a decreased uptake of cysteine, gluta-
mate, and glycine, which combined produce the antiox-
idant glutathione. To counter this potential reduction in
glutathione, there may be a cellular response to down-
regulate expression of the basolateral zinc transporter
to increase the intracellular pool of zinc, which while
acting as an antioxidant, can protect the host against
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Eimeria-induced oxidative damage (Georgieva et al.,
2011).
The HDP are members of the innate immune system
and possess both antimicrobial and immunomodulatory
activities (reviewed in Cuperus et al., 2013; Zhang and
Sunkara, 2014). The AvBD show antibacterial activity
against a number of Gram-positive and Gram-negative
bacteria. To our knowledge, there are no published re-
ports showing AvBD activity against protozoa, such as
Eimeria. The HDP also play an important role in regu-
lating the host immune response to infections by bind-
ing directly to chemokine receptors, inducing proinflam-
matory cytokine expression and showing chemotactic
properties.
In our study, there was differential expression of
AvBD mRNA in the Ross and 2 Fayoumi lines. There
were many changes in AvBD mRNA expression in the
Fayoumi lines compared to the Ross chickens. In the
duodenum, AvBD10, 11, 12, and 13 mRNA were up-
regulated in Fayoumi line M15.2, whereas only AvBD10
mRNA was upregulated in Ross chickens and Fayoumi
line 5.1. In contrast, in the jejunum there was down-
regulation of all 6 AvBD mRNA in both Fayoumi lines
M5.1 and M15.2. E. maxima preferentially affects the
jejunum, so it was reasonable to expect that there might
be downregulation of AvBD mRNA in the jejunum to
promote survival of E. maxima. Because the AvBD are
secreted peptides, the upregulation of AvBD mRNA
in the duodenum of Fayoumi line M15.2 could repre-
sent a compensatory response to the downregulation
of AvBD mRNA in the jejunum. This could result in
enhanced resistance to E. maxima challenge compared
to Fayoumi line M5.1; however, Kim et al. (2008) re-
ported the opposite result, i.e., Fayoumi line M5.1 was
more resistant to E. maxima challenge than Fayoumi
line M15.2 based on BW gain depression. In our study,
we did not observe a difference in BW gain depression
between Fayoumi lines M5.1 and M15.2. Thus, it ap-
pears that the increase in AvBD mRNA expression in
the duodenum of Fayoumi line M15.2 had no significant
effect on BW gain. The changes in AvBD mRNA ex-
pression may play a more important role in modulating
the immune system.
Chicken LEAP2 is a 40-amino-acid cationic peptide
that has broad-acting antimicrobial activity against a
number of bacterial pathogens (Townes et al., 2009).
Su et al. (2017) showed that LEAP2 mRNA was ex-
pressed in the epithelial cells lining the intestinal villi
and thus might be affected by Eimeria in the intesti-
nal lumen. LEAP2 mRNA was consistently downregu-
lated following challenge with E. acervulina, E. max-
ima, E. tenella, or E. praecox in broilers and lay-
ers (Casterlow et al., 2011; Sumners et al., 2011;
Paris and Wong, 2013; Fetterer et al., 2014; Su
et al., 2014, 2015, 2017). In the model proposed by
Paris and Wong (2013), LEAP2 was hypothesized to
play a role in modulating an Eimeria infection, such
that a more resistant chicken would be expected to
show less downregulation of LEAP2 mRNA. Because
there was no difference in BW gain depression be-
tween the Ross and Fayoumi lines, the precise role for
LEAP2 in mediating an Eimeria infection remains to be
determined.
In the current study, we also observed downregula-
tion of LEAP2 mRNA in all 3 intestinal segments of
Ross broilers, in the duodenum and jejunum of Fay-
oumi line M5.1 and in only the ileum of Fayoumi line
M15.2. One proposed explanation for the downregula-
tion of LEAP2 following an Eimeria challenge is short-
ening of the villi and a generalized effect on gene ex-
pression (Su et al., 2017). This is a possible explanation
for the jejunum in Fayoumi line M5.1, where all genes
examined were downregulated. However, in the jejunum
and ileum of Ross chickens, there was downregulation
of amino acid transporter and LEAP2 mRNA, but no
changes for AvBD mRNA. Furthermore, in the duode-
num of Fayoumi line M5.1 there was downregulation of
all transporter and LEAP2 mRNA, but upregulation of
AvBD10 mRNA. Thus, a simple shortening of the villi
cannot be the sole reason for downregulation of gene
expression.
In most pathogen challenge studies, the focus is on
the change in HDP expression following challenge. The
homeostatic level of HDP expression, however, may also
play an important role in mediating the response to a
pathogen. In our study, Fayoumi line M15.2 had greater
relative expression of the AvBD mRNA in the duode-
num and ileum compared to the Ross and Fayoumi line
M5.1. In contrast, Fayoumi line M15.2 showed lower
homeostatic expression of AvBD10, 11, and 13 in the
jejunum compared to Ross chickens, with Fayoumi line
M5.1 intermediate. Because E. maxima, which causes
lesions mainly in the jejunum, was used for the chal-
lenge, the lack of a difference in BW depression be-
tween Ross and the Fayoumi lines may be related to
the similar homeostatic AvBD mRNA expression lev-
els in the jejunum. Challenge with different Eimeria
species such as E. acervulina or E. tenella, which cause
lesions mainly in the duodenum or ileum and cecum,
respectively, might be expected to affect Fayoumi line
M15.2 less than Ross and Fayoumi line M5.1 due to
greater homeostatic AvBD mRNA levels. Consistent
with this idea, Pinard-van der Laan et al. (1998) showed
that Fayoumi chickens showed less severe lesions and re-
duced weight gain depression compared to Rhode Island
Red and White Leghorn chickens following challenge
with E. tenella. The response to a pathogen may be a
combination of the homeostatic and pathogen-induced
levels of HDP mRNA expression. Fayoumi line M15.2
had not only the greatest homeostatic AvBD mRNA
but also the greatest E. maxima-induced AvBD mRNA
levels in the duodenum.
In summary, although a reduction in BW gain
was similar among Ross chickens and the 2 Fay-
oumi lines, homeostatic HDP mRNA expression and
Eimeria-induced transporter and HDP mRNA expres-
sion showed tissue- and genetic line-specific differences.
Fayoumi line M15.2 had the greatest homeostatic and
Eimeria-induced expression of AvBD mRNA in the
duodenum. Common downregulation of the mRNA for
4400 SU ET AL.
the amino acid transporters b0,+AT and EAAT3 and
the HDP LEAP2 in the Ross and Fayoumi lines sup-
ports our previous conclusion on the importance of
these genes in the host response to Eimeria challenge.
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